Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Nippon Shinyaku and Seikagaku terminate NS-7201 license agreement

March 9, 2004

Technology transfer completed in Actelion/Merck renin alliance

March 8, 2004

Promising effects and safety profile found for PT-141 in erectile dysfunction

March 5, 2004

Uroxatral launched to primary-care physicians

March 5, 2004

Good safety and pharmacokinetic profile found for a buccal testosterone formulation

March 5, 2004

Endpoint met in phase IIa study of DMI-7958

March 4, 2004

Solifenacin reported both safe and effective in overactive bladder

March 4, 2004

Duloxetine improves voiding and quality of life of women with stress urinary incontinence

March 3, 2004

Acetylcysteine improves cardiovascular morbidity in renal failure

March 2, 2004

Sosei and Arachnova in licensing agreement in stress urinary incontinence

March 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...